In the aftermath of the Affordable Care Act's passage, the smart money began scouring for companies that would benefit from the Act's implementation. Many wise asset managers honed in on the pharmaceutical wholesalers - The Big Three, as they are known. On the surface, the sector and its players seemed to be well-positioned: 90%+ market share concentrated in three companies, high barriers to entry, and robust underlying growth trends - e.g., an aging US population and an explosion in both specialty and generic pharmaceutical products for sale.
Over the last three years, share prices of each have grown substantially: McKesson (NYSE:MCK) 132%+, Cardinal Health (NYSE:CAH) 68%+, and AmerisourceBergen (NYSE:ABC) 77%...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|